ALX Oncology Holdings Inc. (ALXO) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -18.65M | -18.98M | -17.09M | -23.41M | -24.66M | -32.05M | -25.38M | -26.57M | -37.92M | -39.68M | -31.16M | -31.71M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 24.39% | 40.77% | 32.64% | 11.89% | 34.97% | 19.23% | 18.56% | 16.22% | -36.34% | -91.98% | -0.89% | -86.56% |
| Net Income | -17.93M | -22.85M | -22.14M | -25.95M | -30.75M | -29.16M | -30.71M | -39.4M | -35.58M | -45.47M | -50.99M | -34.16M |
| Depreciation & Amortization | 150K | 151K | 153K | 191K | 211K | 214K | 224K | 220K | 214K | 207K | 209K | 513K |
| Stock-Based Compensation | 0 | 2.71M | 2.52M | 2.14M | 5.22M | 5.86M | 6.95M | 7.25M | 7.03M | 6.72M | 6.96M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11.62M | -1.84M | 0 |
| Other Non-Cash Items | 2.77M | 272K | 253K | 3.39M | 19K | -195K | -523K | -849K | -1.03M | 10.15M | 372K | 4.65M |
| Working Capital Changes | -3.64M | 739K | 2.12M | -3.17M | 645K | -8.76M | -1.32M | 6.21M | -8.56M | 331K | 14.13M | -2.71M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.21M | -1.67M | 1.68M | 965K | -556K | -3.78M | -194K | 1.88M | -2.33M | -4.48M | 8.89M | -5.71M |
| Cash from Investing | -105.04M | 11.23M | 21.39M | 22.32M | 27.64M | 33.18M | 25.69M | 907K | 26.47M | -16.67M | 12.81M | 6.21M |
| Capital Expenditures | -50K | -49K | -56K | -47K | -60K | -60K | -149K | -90K | -148K | -148K | 1.3M | -1.74M |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 50.94K | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -50.94K | 0 | 0 |
| Cash from Financing | 139.59M | 678K | -159K | -222K | 65K | 328K | 251K | 27.15M | 3.09M | 59.17M | -111K | 343K |
| Debt Issued (Net) | -1.61M | -660K | -160K | -237K | -307K | -76K | -358K | -218K | -175K | -63K | -111K | -107K |
| Equity Issued (Net) | 141.21M | 1.34M | 0 | 15K | 372K | -29.3M | 75K | 26.2M | 3.02M | 59.23M | 0 | 450K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 1K | 0 | 0 | 29.71M | 534K | 1.17M | 237K | 0 | 0 | 0 |
| Net Change in Cash | 15.91M | -7.07M | 4.14M | -1.31M | 3.05M | 1.47M | 568K | 1.49M | -8.37M | 2.82M | -18.45M | -25.16M |
| Free Cash Flow | -18.7M | -19.03M | -17.15M | -23.45M | -24.72M | -32.11M | -25.52M | -26.66M | -38.07M | -39.83M | -29.86M | -33.45M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 24.37% | 40.73% | 32.81% | 12.02% | 35.06% | 19.38% | 14.51% | 20.31% | -33.56% | -89.13% | 3.92% | -93.86% |
| FCF per Share | -0.34 | -0.35 | -0.32 | -0.44 | -0.46 | -0.61 | -0.48 | -0.51 | -0.76 | -0.81 | -0.73 | -0.82 |
| FCF Conversion (FCF/Net Income) | 1.04x | 0.83x | 0.77x | 0.90x | 0.80x | 1.10x | 0.83x | 0.67x | 1.07x | 0.87x | 0.61x | 0.93x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |